Table 1 Patient demographics (n = 37)
From: Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial
Characteristics | Arm A | Arm B | Arm C | All patients |
|---|---|---|---|---|
(n = 13) | (n = 12) | (n = 12) | (n = 37) | |
Age on study, years | ||||
Median, range (minimum to maximum) | 64.0 (42.0–85.0) | 51.5 (30.0–78.0) | 65.0 (43.0–78.0) | 63.0 (30.0–85.0) |
Sex, no. (%) | ||||
Female to male | 6/7 (46.2/53.8) | 6/6 (50.0/50.0) | 7/5 (58.3/41.7) | 19/18 (51.4/48.6) |
Race, no. (%) | ||||
White | 11 (84.6) | 10 (83.3) | 11 (91.7) | 32 (86.5) |
Black or African American | 2 (15.4) | 0 (0) | 0 (0) | 2 (5.4) |
Asian | 0 (0) | 1 (8.3) | 0 (0) | 1 (2.7) |
Native Hawaiian or other Pacific islander | 0 (0) | 1 (8.3) | 0 (0) | 1 (2.7) |
Unknown | 0 (0) | 0 (0) | 1 (8.3) | 1 (2.7) |
Ethnicity, no. (%) | ||||
Hispanic or Latino | 2 (15.4) | 2 (16.7) | 2 (16.7) | 6 (16.2) |
Non-Hispanic | 11 (84.6) | 10 (83.3) | 9 (75.0) | 30 (81.1) |
Unknown | 0 (0) | 0 (0) | 1 (8.3) | 1 (2.7) |
Stage, no. (%) | ||||
I | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
II | 0 (0) | 0 (0) | 12 (100.0) | 12 (32.4) |
III | 2 (15.4) | 2 (16.7) | 0 (0.0) | 4 (10.8) |
IV | 11 (84.6) | 10 (83.3) | 0 (0.0) | 21 (56.8) |
